On the other hand, this study offers preclinical evidence supporting acriflavine’s therapeutic potential for VHL-associated hemangioblastomas, based on patient-derived cell cultures, which are better at preserving original tumor characteristics than established cell lines. The gene discussed is VHL; the disease is hemangioblastoma.